NASDAQ:CYTK

Cytokinetics - CYTK News Today

$35.20

-0.13 (-0.37%)

(As of 03/20/2023 12:00 AM ET)

Add

Compare

Today's Range: $34.55
▼
$35.51
50-Day Range: $35.20
▼
$45.71
52-Week Range: $33.60
▼
$55.80

Volume: 841,079 shs
Average Volume: 981,721 shs
Market Capitalization: $3.35 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $57.71

Institutional Ownership

Get Cytokinetics News Delivered to You Automatically

CYTK Media Mentions By Week

CYTK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYTK
News Sentiment
▼
0.60

0.35
▲
Average
Medical
News Sentiment

CYTK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYTK Articles
This Week
▼
6

4
▲
CYTK Articles
Average Week

Source

Source	Headline
	Peregrine Capital Management LLC Increases Stock Position in Cytokinetics, Incorporated (NASDAQ:CYTK) marketbeat.com - March 19 at 6:21 AM
	Insider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Sells 12,500 Shares of Stock marketbeat.com - March 17 at 4:48 PM
	Cytokinetics Reports Fourth Quarter 2022 Financial Results finance.yahoo.com - March 20 at 8:01 AM
	Mizuho Securities Sticks to Their Buy Rating for Cytokinetics (CYTK) markets.businessinsider.com - March 18 at 10:58 PM
	Fady Ibraham Malik Sells 4,000 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) Stock americanbankingnews.com - March 11 at 6:34 AM
	Cantor Fitzgerald Reiterates Overweight Rating for Cytokinetics (NASDAQ:CYTK) americanbankingnews.com - March 11 at 1:56 AM
	Industry Analysts Just Upgraded Their Cytokinetics, Incorporated (NASDAQ:CYTK) Revenue Forecasts By 15% finance.yahoo.com - March 3 at 5:47 PM
	Cytokinetics Receives Complete Response Letter From FDA for New Drug Application for Omecamtiv Mecarbil finance.yahoo.com - March 1 at 2:15 PM
	FDA Rejects Cytokinetics' Heart Failure Treatment Candidate finance.yahoo.com - March 1 at 2:15 PM
	Is a Surprise Coming for Cytokinetics (CYTK) This Earnings Season? finance.yahoo.com - February 28 at 12:12 PM
	Cytokinetics Announces Three Upcoming Presentations at the American College of Cardiology 72nd Annual Scientific Session finance.yahoo.com - February 24 at 5:18 PM
	Cytokinetics to Announce Fourth Quarter Results on March 1, 2023 finance.yahoo.com - February 15 at 8:57 PM
	Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program finance.yahoo.com - January 30 at 9:19 AM
	Investing in Cytokinetics (NASDAQ:CYTK) five years ago would have delivered you a 369% gain finance.yahoo.com - January 25 at 7:04 AM
	Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Maravai Lifesciences Holdings (MRVI) markets.businessinsider.com - January 17 at 12:58 PM
	Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 13 at 3:32 PM
	Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 3 at 8:07 PM
	Mizuho Securities Keeps Their Buy Rating on Cytokinetics (CYTK) markets.businessinsider.com - December 30 at 12:47 PM
	Newsflash: Cytokinetics, Incorporated (NASDAQ:CYTK) Analysts Have Been Trimming Their Revenue Forecasts finance.yahoo.com - December 15 at 12:27 PM
	Cytokinetics (CYTK) Up Despite Unfavorable FDA Committee Voting finance.yahoo.com - December 15 at 12:27 PM
	Cytokinetics AdComm Outcome Might Be Blessing In Disguise, This Analyst Said finance.yahoo.com - December 14 at 3:21 PM
	Why Cytokinetics Is Soaring After A 'Bruising' FDA Meeting For Its Heart Drug finance.yahoo.com - December 14 at 10:21 AM
	Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil finance.yahoo.com - December 13 at 8:31 PM
	Cytokinetics Stock Trading Halted Today finance.yahoo.com - December 13 at 9:14 AM
	Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil finance.yahoo.com - December 9 at 5:36 PM
	Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND finance.yahoo.com - December 8 at 9:32 AM
	Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136 finance.yahoo.com - December 7 at 1:03 PM
	Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND finance.yahoo.com - December 1 at 6:34 PM
	Cytokinetics Third Quarter 2022 Earnings: Misses Expectations finance.yahoo.com - November 8 at 8:51 AM
	Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022 finance.yahoo.com - November 7 at 5:28 PM
	Cytokinetics Announces Three Upcoming Presentations at the American Heart Association Scientific Sessions 2022 finance.yahoo.com - October 31 at 10:41 AM
	Cytokinetics: 2 Catalysts For Heart Failure Drug Make This Worth A Look seekingalpha.com - October 26 at 6:01 AM
	Cytokinetics CEO: Why It's OK Not Being An Overnight Success finance.yahoo.com - October 25 at 2:59 PM
	Cytokinetics to Announce Third Quarter Results on November 3, 2022 finance.yahoo.com - October 20 at 6:27 PM
	Is Cytokinetics (CYTK) a Good Long-Term Investment? finance.yahoo.com - October 18 at 2:58 PM
	Cytokinetics: Surprise Adcomm For Omecamtiv Causing Concern (NASDAQ:CYTK) - Seeking Alpha seekingalpha.com - October 17 at 11:37 AM
	Is Cytokinetics (CYTK) Outperforming Other Medical Stocks This Year? - Nasdaq nasdaq.com - October 14 at 11:16 AM
	Novartis to cut its Irish workforce by up to 25% - Yahoo Finance finance.yahoo.com - October 13 at 3:25 PM
	Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis - Yahoo Finance finance.yahoo.com - October 12 at 6:19 PM
	Cytokinetics (CYTK) to Continue ALS Study on Reldesemtiv finance.yahoo.com - October 11 at 4:06 PM
	Where Cytokinetics Stands With Analysts - Cytokinetics (NASDAQ:CYTK) - Benzinga benzinga.com - October 11 at 11:06 AM
	Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis - GlobeNewswire globenewswire.com - October 10 at 8:34 AM
	Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis finance.yahoo.com - October 10 at 8:34 AM
	IJR, LTHM, EXLS, CYTK: Large Outflows Detected at ETF - Nasdaq nasdaq.com - October 5 at 12:37 PM
	Coca-Cola Price Target Cut By This Analyst? Plus Rocket Pharmaceuticals Likely To Rally Around 306% By Benzinga - Investing.com UK uk.investing.com - October 3 at 1:33 PM
	Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting - GlobeNewswire globenewswire.com - October 2 at 12:32 PM
	Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting finance.yahoo.com - October 2 at 12:32 PM
	Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HCM Society Scientific Sessions - GlobeNewswire globenewswire.com - September 30 at 3:00 PM
	Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HCM Society Scientific Sessions finance.yahoo.com - September 30 at 3:00 PM
	Cytokinetics Announces Call for Proposals for Its Fifth Annual Communications Grant Program - GlobeNewswire globenewswire.com - September 28 at 7:55 AM
	Cytokinetics Announces Call for Proposals for Its Fifth Annual Communications Grant Program finance.yahoo.com - September 28 at 7:55 AM
	Cytokinetics Announces Upcoming Presentations at the 2022 Inaugural HCM Society Scientific Sessions and the HFSA Annual Scientific Meeting - Yahoo Finance finance.yahoo.com - September 26 at 8:06 PM

Get Cytokinetics News Delivered to You Automatically

This page (NASDAQ:CYTK) was last updated on 3/21/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cytokinetics - CYTK News Today

CYTK Media Mentions By Week

CYTK Media Sentiment

CYTK News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info